| Literature DB >> 28132011 |
Malin Ander1, Anna Wikman1, Brjánn Ljótsson2, Helena Grönqvist1, Gustaf Ljungman3, Joanne Woodford4, Annika Lindahl Norberg1, Louise von Essen1.
Abstract
INTRODUCTION: A subgroup of adolescents and young adults diagnosed with cancer during adolescence reports elevated levels of anxiety and depressive symptoms and unmet needs for psychological support. Evidence-based psychological treatments tailored for this population are lacking. This protocol describes a feasibility study of a guided-internet-administered self-help programme (YoungCan) primarily targeting symptoms of anxiety and depression among young persons diagnosed with cancer during adolescence and of the planned study procedures for a future controlled trial. METHODS/ANALYSIS: The study is an uncontrolled feasibility trial with a pre-post and 3-month follow-up design. Potential participants aged 15-25 years, diagnosed with cancer during adolescence, will be identified via the Swedish Childhood Cancer Registry. 30 participants will be included. Participants will receive YoungCan, a 12-week therapist-guided, internet-administered self-help programme consisting primarily of cognitive-behavioural therapy organised into individually assigned modules targeting depressive symptoms, worry and anxiety, body dissatisfaction and post-traumatic stress. Interactive peer support and psychoeducative functions are also available. Feasibility outcomes include: recruitment and eligibility criteria; data collection; attrition; resources needed to complete the study and programme; safety procedures; participants' and therapists' adherence to the programme; and participants' acceptability of the programme and study methodology. Additionally, mechanisms of impact will be explored and data regarding symptoms of anxiety, depression, post-traumatic stress, body dissatisfaction, reactions to social interactions, quality of life, axis I diagnoses according to the Mini International Neuropsychiatric Interview and healthcare service use will be collected. Exploratory analyses of changes in targeted outcomes will be conducted. ETHICS/DISSEMINATION: This feasibility protocol was approved by the Regional Ethical Review Board in Uppsala, Sweden (ref: 2016/210). Findings will be disseminated to relevant research, clinical, health service and patient communities through publications in peer-reviewed and popular science journals and presentations at scientific and clinical conferences. TRIAL REGISTRATION NUMBER: ISRCTN97835363. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.Entities:
Keywords: adolescence; cognitive behavioural therapy; feasibility study; neoplasms; psychological treatment
Mesh:
Year: 2017 PMID: 28132011 PMCID: PMC5278290 DOI: 10.1136/bmjopen-2016-013906
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Figure 1CONSORT diagram. GAD-7, Generalized Anxiety Disorder 7-item scale; MINI, Mini-International Neuropsychiatric Interview; PHQ-9, 9-item Patient Health Questionnaire.
Feasibility outcomes and progression criteria
| Outcome | Evaluation | Progression criteria to controlled trial* |
|---|---|---|
| Recruitment and eligibility |
Number of people identified via the Swedish Childhood Cancer Registry, invited via telephone, invited via letter, assessed for eligibility | No criteria set |
|
Percentages of people interested in participation, assessed for eligibility, meeting the inclusion criteria and included, of the total number identified | ≥15% interested in participating of the total number identified≥10% included of the total number identified | |
|
Ambiguities regarding eligibility criteria | No criteria set | |
|
Numbers scoring above/under recommended cut-offs on clinical outcome measures | No criteria set | |
|
Reasons for ineligibility | No criteria set | |
|
Reasons for non-participation | No criteria set | |
| Data collection |
Percentage of participants completing assessments | 70% answering all questions at all assessments |
|
Numbers of missing items relating to clinical, psychological and health economics outcomes | No criteria set | |
|
Types and number of potential uncertainties in diagnostic interviews | No criteria set | |
| Attrition |
Rates of dropout from study and programme | No criteria set |
| Resources needed to complete the study and the programme | Length of time for: Participants to work through the programme Participants to complete questionnaires and interviews Therapists to deliver the programme Study personnel to administer the study | No criteria set |
| Safety procedures |
Ambiguities regarding standard safety procedures Types and numbers of measures undertaken to assure patient safety Types and numbers of unforeseen safety issues | No criteria set |
| Participants’ adherence to the ICBT and use of optional support functions | Number of:
Logins Opened ICBT items, completed homework assignments Chat sessions, forum posts, private messages, diary posts, questions in the Q&A function Visits to the chat room, forum, library and Q&A functions | 70% completing the introduction ICBT chapter, and the first two parts of an individually assigned chapter |
| Therapists’ adherence to programme |
Content of online written therapist-participant communication | No criteria set |
| Participants’ acceptability of programme and data collection and exploration of mechanisms of impact |
Reasons for poor attendance and withdrawal from study and programme | No criteria set |
|
Impressions and experiences of working with the programme (including positive and negative consequences) and of completing questionnaires and interviews | 70% of participants using the programme reporting that it is helpful |
*If one or more criteria are not met, revisions should be considered before proceeding to a controlled trial.
ICBT, internet-based cognitive–behavioural therapy; Q&A, Question and Answer function.
Outcome measures at each assessment
| Measure | Eligibility interview | Baseline assessment | Assessment at 3 months postbaseline | Assessment at 6 months postbaseline | Mode of administration |
|---|---|---|---|---|---|
| Demographics and clinical variables | x | Online | |||
| PHQ-9 | x | x | x | Online | |
| GAD-7 | x | x | x | Online | |
| BIS | x | x | x | Online | |
| PCL-C | x | x | x | Online | |
| SIAS | x | x | x | Online | |
| EQ-5D | x | x | x | Online | |
| Modified TiC-P | x | x | x | Online | |
| MINI | x | x | x | Telephone |
BIS, Body Image Scale; EQ-5D, EuroQol 5-dimension questionnaire; GAD-7, Generalized Anxiety Disorder 7-item scale; MINI, Mini-International Neuropsychiatric Interview; PHQ-9, 9-item Patient Health Questionnaire; PCL-C, Posttraumatic Stress Disorder Checklist-Civilian version; SIAS, Social Interaction Anxiety Scale; TiC-P, Trimbos and Institute of Medical Technology Assessment Cost Questionnaire for Psychiatry.